HOUSE DEVICE REFORM "SCOPE OF REVIEW" COMPROMISE HAS SUPPORT OF SEN. KENNEDY, INDUSTRY; SENATE PASSES FDA REFORM BILL BY 98-2 ON SEPT. 24
This article was originally published in The Gray Sheet
Executive Summary
A compromise reached by FDA and the House Commerce Committee on scope of review language in the House FDA device reform bill (HR 1710) has the support of Sen. Edward Kennedy (D-Mass.) and device manufacturers, bolstering the prospects for adoption of the language during conference on the legislation.